Cargando…

Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy

BACKGROUND: The efficacy of conversion therapy for patients with unresectable hepatocellular carcinoma (HCC) is a common clinical concern. AIM: To analyse the prognostic factors of overall survival (OS) in patients with unresectable HCC who received conversion therapy. METHODS: One hundred and fifty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jia-Lin, Luo, Jun-Yang, Jiang, Zai-Bo, Huang, Si-Bo, Chen, Ge-Run, Ran, Hui-Ying, Liang, Qi-Yue, Huang, Ming-Sheng, Lai, Li-Sha, Chen, Jun-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280795/ https://www.ncbi.nlm.nih.gov/pubmed/37346152 http://dx.doi.org/10.3748/wjg.v29.i20.3168

Ejemplares similares

Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Zhao, Dongxu, et al.
Publicado: (2023)

Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
por: Chen, Yi-Di, et al.
Publicado: (2022)

Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
por: Chen, Yong-He, et al.
Publicado: (2020)

Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
por: Zhang, Ze-Feng, et al.
Publicado: (2018)

Inflammation-based Glasgow prognostic score as an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma
por: Chen, Guan-Jun, et al.
Publicado: (2021)

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
por: Chen, Kang, et al.
Publicado: (2022)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma
por: Hu, Yue, et al.
Publicado: (2023)

Deep learning-based radiomics based on contrast-enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma
por: Huang, Zhe, et al.
Publicado: (2022)

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
por: Chen, Yen-Yang, et al.
Publicado: (2020)

Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer
por: Hitchcock, Kathryn E, et al.
Publicado: (2017)

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2023)

Medium-term efficacy of arthroscopic debridement vs conservative treatment for knee osteoarthritis of Kellgren-Lawrence grades I-III
por: Lv, Bo, et al.
Publicado: (2021)

Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy
por: Wang, Jin, et al.
Publicado: (2020)

Development and Assessment of Nomogram Based on AFP Response for Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhang, Yi, et al.
Publicado: (2023)

Contemporary characteristics, management, and outcomes of patients hospitalized for atrial fibrillation in China: results from the real-world study of Chinese atrial fibrillation registry
por: Zhao, Qing-Yan, et al.
Publicado: (2020)

Nomogram based on inflammation-related markers for predicting survival of patients undergoing hepatectomy for hepatocellular carcinoma
por: Pu, Tian, et al.
Publicado: (2021)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy
por: Li, Jian-Xu, et al.
Publicado: (2022)

RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
por: Li, Jian, et al.
Publicado: (2022)

A case of a superficial spreading melanoma in situ diagnosed via digital dermoscopic monitoring with high dynamic range conversion
por: Sato, Toshitsugu, et al.
Publicado: (2014)

Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma
por: An, Yang, et al.
Publicado: (2018)

Dynamic Nomogram for Predicting Macrovascular Invasion of Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yan, Huiwen, et al.
Publicado: (2022)

PNI-Based Nomograms to Predict Tumor Progression and Survival for Patients with Unresectable Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
por: Lei, Kai, et al.
Publicado: (2023)

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
por: Stewart, Susan L, et al.
Publicado: (2016)

Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome
por: Lin, Lang, et al.
Publicado: (2018)

A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study
por: Zhang, Li, et al.
Publicado: (2019)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

A novel inflammation‐based nomogram system to predict survival of patients with hepatocellular carcinoma
por: Chen, Jinbin, et al.
Publicado: (2018)

Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study
por: Yoon, Jae Hyun, et al.
Publicado: (2022)

Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients
por: Huang, Xiao-Min, et al.
Publicado: (2023)

Clinical and genetic features of transthyretin-related familial amyloid polyneuropathy in China
por: Liu, Lei, et al.
Publicado: (2020)

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation
por: Dopkins, Nicholas, et al.
Publicado: (2023)

Interconnections of Pseudomonas aeruginosa Quorum-Sensing Systems in Intestinal Permeability and Inflammation
por: Singh, Vijay K., et al.
Publicado: (2023)

Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization?
por: Cao, Xin, et al.
Publicado: (2022)

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
por: Zhu, Xiao-Dong, et al.
Publicado: (2022)

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib
por: Harmon, Charles S, et al.
Publicado: (2011)

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients
por: Zhang, Bo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljki38fr008pvjiuha3shcl4r2